Skip to content

DEL PHARMA

Active
General partnershipfounded 20197 yrs activeCh. Rive droite Canal du Centre 39, 7000 Mons, BelgiumKBO/BCE: BE 0721.527.966
Summary

DEL PHARMA has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €10,340 and a net result of €2,119. Equity is shrinking by ~13.8% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.7% (low).

Risk analysisWatch ReportCompare
DEL PHARMAActiveChecked score 61/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€33,315total assets 2024
Equity
€10,340
Profit
€2,119
Turnover not published (abridged schema)
Financially healthy?
61 Healthy Checked score 2024
Bankruptcy chance 12 m
0.7%
Who decides
Accounts 32 d early0 of 2 deeds read
Why 61- Limited track record- Higher-failure-rate sector- Annual accounts: weaker financial profile- Higher-failure-rate region+ Lower-risk legal formLatest accounts filed on timeShow the evidence

Checked score

Score 2024
61 / 100
Healthy
Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability77=
Solvency56▲+11
Growth32=
Track record100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity short (current ratio 0.99 against 0.87 in 2023; short-term debt: 51% and cash: 2.1% of total assets), and 69% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
31%
Return on assets
6.4%
Age of the figures
21 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
32 d early
2024
41 d early
2023
46 d early
2022
45 d early
2021
8 d early
2020
28 d late
2019
61 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Total assets 20246 fiscal years filed €33,315 View
  • Active since 2019founded 25-02-2019 7 years View

By topic

Financials

Fiscal year
2024
Total assets
€33,315
Profit
€2,119
Solvency
31.0%
Total assets▼ 18.3%
Net result
20192024
Go to Financials

Timeline

Events
9
Since
2020
Next accounts
by 31-07-2027
  1. 29-06-2026Annual accounts filed
  2. 20-06-2025Annual accounts filed
  3. 15-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
General partnership
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
25-02-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure